姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Ceng,Zi-Ling | Chairman | 3.62% | |
Lin,Ting-Kuan | Director | 15.47% | ANFU HEALTHCARE NO. 2 LIMITED PARTNERSHIP |
Xu,Zhang-Li | Director | 0.42% | |
Wei,Yao-Hui | Independent Director | 0.00% | |
Shi,Fan-Quan | Independent Director | 0.00% | |
Zhang,Da-Ci | Independent Director | 0.00% | |
Huang,Qiong-Yu | Independent Director | 0.00% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 12,297 | 1,208 | 2,177 |
Operating cost | 440 | 125 | 229 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 11,857 | 1,083 | 1,948 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 11,857 | 1,083 | 1,948 |
Operating expenses | 97,621 | 73,647 | 72,759 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -85,764 | -72,564 | -70,811 |
Non-operating income and expenses | -1,795 | -721 | -129 |
Net profit (loss) before tax | -87,559 | -73,285 | -70,940 |
Income tax expense (benefits) | - | - | - |
Net profit (loss) of ongoing business for the current period | -87,559 | -73,285 | -70,940 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -87,559 | -73,285 | -70,940 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -87,559 | -73,285 | -70,940 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | -2 | -2 | -2 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 366,378 | 93,951 | 95,070 |
Non-current asset | 163,327 | 170,706 | 178,047 |
Total asset | 529,705 | 264,657 | 273,117 |
Current liability | 20,914 | 18,467 | 19,116 |
Non-current liability | 101,701 | 106,262 | 113,462 |
Total liability | 122,615 | 124,729 | 132,578 |
share capital | 494,485 | 344,485 | 324,485 |
Equity - secruity token | - | - | - |
capital reserve | 437,842 | 233,121 | 180,447 |
retained earning | -525,237 | -437,678 | -364,393 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 407,090 | 139,928 | 140,539 |
Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 8 | 4 | 4 |